Michael Gainey
Family Medicine · Cynthiana, KYNPI 1194796169
Payments from drug & device makers
Across 143 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$387
- AbbVie$242
- GSK$182
- Pfizer$126
- Dexcom, Inc.$116
- Bayer$102
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,297 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 11 | $39,111 |
| EliquisApixaban | 95 | $35,789 |
| CaplytaLumateperone Tosylate | 11 | $15,405 |
| OzempicSemaglutide | 11 | $15,014 |
| Spiriva RespimatTiotropium Bromide | 19 | $10,481 |
| Aripiprazole | 59 | $9,205 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $9,143 |
| VascepaIcosapent Ethyl | 60 | $9,042 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 96 | $8,508 |
| Fluphenazine Hcl | 17 | $7,334 |
| TradjentaLinagliptin | 14 | $6,310 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,702 |
| Duloxetine Hcl | 80 | $5,057 |
| Paliperidone ErPaliperidone | 33 | $4,990 |
| XareltoRivaroxaban | 12 | $4,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Xarelto | $29 | $43,68223 claims |
| PfizerEliquis | $126 | $35,78995 claims |
| Boehringer IngelheimSpiriva Respimat, Tradjenta | $27 | $16,79133 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $89 | $15,40511 claims |
| Novo NordiskOzempic | $74 | $15,01411 claims |
| GSKBreo Ellipta | $182 | $9,14320 claims |
| Lilly USA, LLCOlanzapine, Humulin 70-30 | $65 | $6,897138 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $74 | $5,70212 claims |
| AstraZenecaSymbicort | $27 | $2,53711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Cynthiana
- Brian MulberryCynthiana$15K
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.